- Home
- SXTP vs ENSC Comparison
SXTP vs ENSC Comparison
Compare SXTP & ENSC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SXTP
- ENSC
- Stock Information
- Founded
- SXTP 2010
- ENSC 2003
- Country
- SXTP United States
- ENSC United States
- Employees
- SXTP N/A
- ENSC N/A
- Industry
- SXTP Biotechnology: Pharmaceutical Preparations
- ENSC Biotechnology: Pharmaceutical Preparations
- Sector
- SXTP Health Care
- ENSC Health Care
- Exchange
- SXTP Nasdaq
- ENSC Nasdaq
- Market Cap
- SXTP 4.3M
- ENSC 4.9M
- IPO Year
- SXTP 2023
- ENSC N/A
- Fundamental
- Price
- SXTP $2.32
- ENSC $2.22
- Analyst Decision
- SXTP Buy
- ENSC
- Analyst Count
- SXTP 2
- ENSC 0
- Target Price
- SXTP $7.00
- ENSC N/A
- AVG Volume (30 Days)
- SXTP 324.9K
- ENSC 230.3K
- Earning Date
- SXTP 08-13-2025
- ENSC 08-13-2025
- Dividend Yield
- SXTP N/A
- ENSC N/A
- EPS Growth
- SXTP N/A
- ENSC N/A
- EPS
- SXTP N/A
- ENSC N/A
- Revenue
- SXTP $802,323.00
- ENSC $6,224,081.00
- Revenue This Year
- SXTP $95.50
- ENSC N/A
- Revenue Next Year
- SXTP $80.78
- ENSC $1,381.48
- P/E Ratio
- SXTP N/A
- ENSC N/A
- Revenue Growth
- SXTP 118.37
- ENSC 256.35
- 52 Week Low
- SXTP $1.41
- ENSC $1.62
- 52 Week High
- SXTP $35.99
- ENSC $14.67
- Technical
- Relative Strength Index (RSI)
- SXTP 50.64
- ENSC 49.53
- Support Level
- SXTP $1.91
- ENSC $2.02
- Resistance Level
- SXTP $2.55
- ENSC $2.30
- Average True Range (ATR)
- SXTP 0.24
- ENSC 0.14
- MACD
- SXTP -0.00
- ENSC 0.02
- Stochastic Oscillator
- SXTP 46.09
- ENSC 43.40
About SXTP 60 Degrees Pharmaceuticals Inc.
60 Degrees Pharmaceuticals Inc operates as a specialty pharmaceutical company with the goal of using biological science and applied research to develop and commercialize new therapies for the prevention and treatment of infectious diseases. The firm's pipeline products under development cover development programs for COVID-19, fungal, tick-borne, and other viral diseases.
About ENSC Ensysce Biosciences Inc.
Ensysce Biosciences Inc is a clinical-stage biotech company using its proprietary technology platforms to develop safer prescription drugs. The company is developing a new class of powerful, tamper-proof opioids that prevent both drug abuse and overdoses. Its products are anticipated to provide safer options to treat severe pain and assist in preventing deaths caused by opioid abuse, reducing human and economic costs. The company's current development pipeline includes two new drug platforms: an abuse-resistant opioid prodrug technology, theTrypsin Activated Abuse Protection, or the TAAP platform, and an over-dose protection opioid prodrug technology, the Multi-Pill Abuse Resistant, or the MPAR platform. The Company currently operates in one business segment, which is pharmaceuticals.